Active Surveillance in Intermediate-Risk Patients: Overall and Cause-Specific Survival From a Large Single-Institution Experience

被引：0
|
作者：
Musunuru, H. B. [1 ]
Klotz, L. [2 ]
Vesprini, D. [3 ]
Zhang, L. [1 ]
Mamedov, A. [3 ]
Sethukavalan, P. [3 ]
Jethava, V. [2 ]
Jain, S. [4 ]
Yamamoto, T. [2 ]
Loblaw, D. A. [3 ]
机构：
[1] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON M4N 3M5, Canada
[2] Sunnybrook Hlth Sci, Toronto, ON, Canada
[3] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada
[4] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2015年 / 93卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2015.07.1112
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2558
引用
收藏
页码：E224 / E224
页数：1
相关论文
共 50 条
  • [1] Cautionary tale of active surveillance in intermediate-risk patients: Overall and cause-specific survival in the Sunnybrook experience.
    Musunuru, Hima Bindu
    Klotz, Laurence
    Vespirini, Danny
    Zhang, Liying
    Mamedov, Alexandre
    Sethukavalan, Perakaa
    Jethava, Vibhuti
    Yamamoto, Toshihiro
    Jain, Suneil
    Loblaw, D. Andrew
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [2] Cause-specific mortality of low and selective intermediate-risk prostate cancer patients with active surveillance or watchful waiting
    Wu, Xiangkun
    Lv, Daojun
    Eftekhar, Md
    Cai, Chao
    Zhao, Zhijian
    Gu, Di
    Liu, Yongda
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (01)
  • [3] Active surveillance in favorable intermediate-risk prostate cancer: A single-center experience
    Bandelier, Q.
    Bastide, C.
    Charvet, A. -L
    Leclercq, L.
    Gondran-Tellier, B.
    Campagna, J.
    Long-Depaquit, T.
    Daniel, L.
    Rossi, D.
    Lechevallier, E.
    Baboudjian, M.
    FRENCH JOURNAL OF UROLOGY, 2024, 34 (01):
  • [4] A comparison of overall and cause-specific survival among patients with low- and intermediate-risk prostate cancer treated with brachytherapy, external beam radiotherapy, or radical prostatectomy
    Ciezki, J. P.
    Reddy, C. A.
    Kupelian, P. A.
    Klein, E. A.
    Robinson, C.
    Chehade, N.
    Angermeier, K.
    Altman, A.
    Ulchaker, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] Overall Survival of Filipino Patients with Squamous Cell Carcinoma of the Head and Neck: A Single-Institution Experience
    Albano, Pia Marie
    Lumang-Salvador, Christianne
    Orosa, Jose, III
    Racelis, Sheryl
    Leano, Modesty
    Angeles, Lara Mae
    Ramos, John Donnie
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (08) : 4769 - 4774
  • [6] Is active surveillance safe for patients with intermediate-risk prostate cancer?
    Chung, Hoseok
    Shin, Bo Sung
    Nam, Deok-Hyun
    Chung, Hoseok
    Kim, Myung Ki
    Jung, Seung Il
    Kang, Taek Won
    Kwon, Dong Deuk
    BJU INTERNATIONAL, 2015, 116 : 4 - 4
  • [7] Overall Survival and Adjuvant Therapy in Women with Ovarian Carcinosarcoma: A Single-Institution Experience
    Nizam, Aaron
    Bustamante, Bethany
    Shan, Weiwei
    Shih, Karin K.
    Whyte, Jill S.
    Sakaris, Antoinette
    dos Santos, Lisa
    Frimer, Marina
    Menzin, Andrew W.
    Truskinovsky, Alexander
    Goldberg, Gary L.
    DIAGNOSTICS, 2019, 9 (04)
  • [8] Epidemiological and Clinical Data in Low- and Intermediate-Risk Neuroblastoma: A Single Institution Experience and Survival Outcomes in Jerusalem
    Sbeih, Ala
    Salami, Khadra
    Saleh, Hani
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S515 - S515
  • [9] LDR-HDR boost in patients with intermediate-risk prostate cancer. A single Institution experience
    Rodriguez Villalba, S.
    Monasor Denia, P.
    Richart Sancho, J.
    Acosta Rojas, A.
    Perez-Calatayud, M. J.
    Perez-Calatayud, J.
    Santos Ortega, M.
    RADIOTHERAPY AND ONCOLOGY, 2021, 158 : S200 - S201
  • [10] Serial Prostate Biopsy and Risk of Lower Urinary Tract Symptoms: Results From a Large, Single-institution Active Surveillance Cohort
    Glass, Allison S.
    Hilton, Joan F.
    Cowan, Janet E.
    Washington, Samuel L.
    Carroll, Peter R.
    UROLOGY, 2014, 83 (01) : 33 - 38
12345